EGFR exon 20 insertion lung cancer has moved from a hard-to-treat subgroup with few specific options to a setting where targeted treatment is now part of routine planning. The change matters because these tumours often do not respond well to older EGFR tablets such as erlotinib, gefitinib, afatinib or osimertinib, even though they carry an EGFR alteration. For 2026 treatment planning, the central question is practical: which FDA-approved options fit where, and how should clin

When it comes to head and neck cancer, early diagnosis is crucial. I want to guide you through the process of identifying symptoms and understanding how doctors diagnose this condition. This knowledge can help you seek care quickly and confidently. At Dr Ehab Ibrahim's private cancer clinic, we focus on rapid access to advanced, personalised care. This approach improves outcomes and quality of life for patients facing head and neck cancer. Understanding Head and Neck Cancer S

For many people with stage 3 head and neck squamous cell carcinoma, surgery is only one part of treatment. The harder question is what should happen before and after surgery to lower the risk of the cancer coming back. Pembrolizumab, a PD-1 checkpoint inhibitor, has already changed treatment for recurrent or metastatic head and neck cancer. The newer question is whether it can help earlier, when the cancer is still considered curable and surgery is planned. This is where neoa

A lung tumour can leave traces of itself in the bloodstream long before it is easy to study with a scan or biopsy. These traces are tiny fragments of genetic material, shed by cancer cells as they grow, die, and interact with the body. For lung cancer, where early diagnosis and timely treatment choices can change the course of care, that signal matters. Circulating tumour DNA, often shortened to ctDNA, is part of the wider field of “liquid biopsy”. Instead of taking tissue fr